Indivior’s Listing on NASDAQ

Freshfields advised Indivior PLC on its additional listing on NASDAQ. Indivior PLC (LSE: INDV), a global pharmaceutical company focused on developing medicines to treat substance use disorders (SUD)...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

QSC LLC’s Acquisition of Seervision

Lenz & Staehelin advises Q-SYS in this transaction. Q-SYS, a division of US-based QSC LLC, has announced a definitive agreement to acquire Seervision, a Swiss-based industry...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here